Evidence map›Paper›PMID 29888292›Full record

ArticleJournal of immunology research2018

Suppression of Th17 Cell Response in the Alleviation of Dextran Sulfate Sodium-Induced Colitis by

Bing Wei, Ran Zhang, Jingbo Zhai, Junfeng Zhu, Fangli Yang, Dan Yue, Xiaoyi Liu, Changlong Lu, Xun Sun

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Immune-enhancement effects ofFood science and biotechnology · 2023
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Nutritional Profile and Health Benefits ofFoods (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Comparison of the healing effects of mesazaline andAnnals of surgical treatment and research · 2022
    Article
  13. Frontiers in pharmacology · 2022
    Review
  14. Effects and Mechanism ofBioMed research international · 2022
    Article
  15. Polysaccharide fromFrontiers in immunology · 2022
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Bing WeiDepartment of Immunology, China Medical University, Shenyang, China.ORCID 0000-0001-9329-4279
Ran ZhangDepartment of Immunology, China Medical University, Shenyang, China.
Jingbo ZhaiDepartment of Immunology, China Medical University, Shenyang, China.
Junfeng ZhuDepartment of Immunology, China Medical University, Shenyang, China.ORCID 0000-0001-5845-0969
Fangli YangDepartment of Immunology, China Medical University, Shenyang, China.
Dan YueDepartment of Immunology, China Medical University, Shenyang, China.
Xiaoyi LiuDepartment of Immunology, China Medical University, Shenyang, China.
Changlong LuDepartment of Immunology, China Medical University, Shenyang, China.ORCID 0000-0001-9589-6839
Xun SunDepartment of Immunology, China Medical University, Shenyang, China.ORCID 0000-0001-5152-657X
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsThe mice were administered with GLP by intragastric gavage daily for two weeks prior to the DSS treatment. Mice were orally administered with 2.5% DSS dissolved in drinking water with GLP or water treatment for 6 days. The mice were killed on day 7 after induction of colitis. Survival rates, body weight loss, colon lengths, histological changes, and disease activity index scores (DAI) were evaluated.

resultsGLP significantly improved survival rates, colon length shortening, body weight loss, histopathological score, and DAI scores in mice with DSS-induced colitis. GLP markedly suppressed the secretions of TNF-

conclusionsGLP prevented inflammation, maintained intestinal homeostasis, and regulated the intestinal immunological barrier functions in mice with DSS-induced colitis.

Indexed as

AnimalsAnti-Inflammatory AgentsBasidiomycotaBiomarkersColitisCytokinesDextran SulfateDisease Models, AnimalDisease ProgressionFungal PolysaccharidesGene ExpressionImmunomodulationImmunophenotypingLeukocytesMaleMiceAnti-Inflammatory AgentsBiomarkersCytokinesDextran SulfateFungal PolysaccharidesTranscription Factors

Identifiers

PMID29888292
PMCPMC5985119
OpenAlexW2804426940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.